Breaking news

AI could end disease, Google DeepMind CEO Demis Hassabis says

The Vision of Google’s DeepMind

Demis Hassabis, acclaimed CEO of Google’s DeepMind, celebrated his revolutionary achievements in artificial intelligence (AI) with a refreshing game of poker. The visionary sees AI as the ultimate tool that could potentially end diseases and bring about what he calls “radical abundance.” This bold foresight aligns with the advancements in AI technologies that are continually shaping the landscape.

The Race to Artificial General Intelligence

DeepMind is spearheading the pursuit of Artificial General Intelligence (AGI), with aspirations to develop machines as versatile and knowledgeable as humans, but with superhuman speed. Hassabis noted, “It’s moving incredibly fast,” pointing out the exponential improvement curve powered by increasing resources and interest. Yet, the race raises questions about the safety and ethical implications of such rapid advancements.

Exciting Developments and Challenges

The latest innovation, Project Astra, signals a new generation of chatbots capable of interpreting the world with remarkable accuracy. However, as Scott Pelley observed during a showcase, these systems still lack imagination and curiosity—a gap Hassabis believes could be bridged in the next five to ten years. This progression mirrors global trends, as seen in current tech developments.

The Bigger Picture

Hassabis envisions AI not only to enrich human endeavors but also to tackle health-related challenges, positing that with AI, the end of disease could indeed be on our horizon. As DeepMind continues to evolve, the potential of AI to affect every aspect of our lives remains both a thrilling and daunting prospect.

Global Perspectives

Globally, the dialogue on AI ethics is crucial. “Guardrails,” as Hassabis calls them, are essential to ensure technologies align with societal values and stay within safe limits. The international community faces the daunting task of setting standards that prevent a ‘race to the bottom’ on safety and ethics.

China Blocks Meta’s $2B Manus Acquisition, Redefining Tech Cross-Border Risks

Beijing has moved to unwind Meta’s $2 billion acquisition of artificial intelligence startup Manus following a regulatory review. The decision adds pressure on cross-border tech deals involving Chinese-linked assets. The case reflects tighter oversight of data, talent, and intellectual property tied to companies with operations in China.

Deal In Turbulence: The Manusgate Episode

Chinese regulators initiated a review shortly after the transaction was announced and have requested that the deal be reversed. Duncan Clark said founders should expect limits when structuring companies linked to China. Market participants have used offshore structures, including Singapore entities, to complete transactions. The current case indicates these structures may still face regulatory intervention.

Geopolitical Stakes And Regulatory Dominance

The review coincides with Meta’s earnings cycle and broader U.S.-China political engagement. Former U.S. President Donald Trump is expected to visit Beijing during the same period. Winston Ma said regulators are focused on whether sensitive technologies, including data and engineering talent, are transferred outside China through corporate restructuring.

Implications For Global Talent And Investment

Chris Pereira, president and CEO of iMpact, said relocating incorporation to jurisdictions such as Singapore does not remove exposure to Chinese regulatory review. Talent mobility remains a key factor in U.S.-China competition. The case may influence how founders and investors structure cross-border AI companies and manage jurisdictional risk.

Data Reversal And The Challenges Ahead

Reversal of data transfers is one of the most complex aspects of unwinding the Manus deal. Industry analysts note that reversing digital data flows is more difficult than separating physical assets. A spokesperson for Meta said the transaction complied with applicable laws. Gary Dvorchak, managing director at Blueshirt Group, said China’s influence over Meta is limited by the company’s restricted presence in the Chinese market.

At the same time, regulatory intervention could still disrupt Manus operations and affect the practical value of the acquisition. China accounted for approximately 11% of Meta’s revenue in 2024, compared with more than 20% from Europe. The distribution highlights exposure to geopolitical developments and regulatory actions affecting cross-border operations. Expanded use of foreign investment review mechanisms by Chinese authorities is prompting companies and investors to reassess deal structures, data flows, and jurisdictional risk.

 

Uol
Aretilaw firm
The Future Forbes Realty Global Properties
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter